The PUBCHEM_BIOASSAY, known as the qHTS Assay for Identification of Novel General Anesthetics, employs a GABAergic mimetic model system in combination with apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA) to establish a competitive binding assay for discovering innovative general anesthetics. With confirmatory properties and categorized accordingly, this assay is assigned to Equus caballus for the assay organism and is described as a binding type of assay. Additionally, it is renowned as a direct single protein target assay, and it has related pubchem assays, including 2385 (Probe Development Summary for Identification of Novel General Anesthetics) and 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection). Has the molecule shown sufficient efficiency and effectiveness to successfully contribute to the overall success of this particular assay in question?